Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
CANC
52
HOLDINGS
21%
ALSO IN SBIO
SBIO
78
HOLDINGS
14%
ALSO IN CANC
SECTOR DRIFT (CANC minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CELCUITY INC. | 3.1% | 3.2% | 3.1% |
|
CG ONCOLOGY, INC. | 2.6% | 3.4% | 2.6% |
|
IDEAYA BIOSCIENCES, INC. | 2.0% | 1.6% | 1.6% |
|
RELAY THERAPEUTICS, INC. | 1.4% | 1.6% | 1.4% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% | 1.4% | 1.4% |
CANC Overweight Relative to SBIO
|
REVOLUTION MEDICINES, INC. | 4.9% |
 |
ASTRAZENECA PLC | 4.3% |
 |
NOVARTIS AG | 4.3% |
|
ELI LILLY & CO | 4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 4.1% |
|
COGENT BIOSCIENCES INC | 3.8% |
|
MERCK & CO. INC. | 3.5% |
|
BRIDGEBIO PHARMA, INC. | 3.5% |
|
IMMUNOME, INC. | 3.5% |
|
BRISTOL-MYERS SQUIBB CO | 3.5% |
CANC Underweight Relative to SBIO
|
KYMERA THERAPEUTICS, INC. | -4.2% |
|
MIRUM PHARMACEUTICALS, INC. | -3.4% |
 |
ALKERMES PLC | -3.3% |
|
APELLIS PHARMACEUTICALS, INC. | -3.1% |
|
APOGEE THERAPEUTICS, INC. | -2.9% |
|
AMICUS THERAPEUTICS INC | -2.7% |
|
CRINETICS PHARMACEUTICALS INC | -2.5% |
|
SPYRE THERAPEUTICS INC | -2.4% |
|
NEWAMSTERDAM PHARMA CO NV | -2.4% |
|
DIANTHUS THERAPEUTICS INC | -2.4% |